220 related articles for article (PubMed ID: 20298971)
1. Characterization of tau fibrillization in vitro.
Xu S; Brunden KR; Trojanowski JQ; Lee VM
Alzheimers Dement; 2010 Mar; 6(2):110-7. PubMed ID: 20298971
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
[TBL] [Abstract][Full Text] [Related]
3. Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain.
Al-Hilaly YK; Foster BE; Biasetti L; Lutter L; Pollack SJ; Rickard JE; Storey JMD; Harrington CR; Xue WF; Wischik CM; Serpell LC
FEBS Lett; 2020 Mar; 594(5):944-950. PubMed ID: 31721178
[TBL] [Abstract][Full Text] [Related]
4. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
[TBL] [Abstract][Full Text] [Related]
5. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of tau self-aggregation and neurotoxicity.
Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
[TBL] [Abstract][Full Text] [Related]
7. In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss.
Snow AD; Cummings JA; Tanzi RE; Lake T
Sci Rep; 2021 Feb; 11(1):3001. PubMed ID: 33589649
[TBL] [Abstract][Full Text] [Related]
8. Tau filament formation in transgenic mice expressing P301L tau.
Götz J; Chen F; Barmettler R; Nitsch RM
J Biol Chem; 2001 Jan; 276(1):529-34. PubMed ID: 11013246
[TBL] [Abstract][Full Text] [Related]
9. Evaluating triggers and enhancers of tau fibrillization.
Kuret J; Congdon EE; Li G; Yin H; Yu X; Zhong Q
Microsc Res Tech; 2005 Jul; 67(3-4):141-55. PubMed ID: 16103995
[TBL] [Abstract][Full Text] [Related]
10. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
Vingtdeux V; Davies P; Dickson DW; Marambaud P
Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
[TBL] [Abstract][Full Text] [Related]
11. The twisted tauopathies: surface interactions of helically patterned filaments seen in alzheimer's disease and elsewhere.
Rochman ND; Sun SX
Soft Matter; 2016 Jan; 12(3):779-89. PubMed ID: 26526630
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies.
Arima K
Neuropathology; 2006 Oct; 26(5):475-83. PubMed ID: 17080728
[TBL] [Abstract][Full Text] [Related]
13. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
[TBL] [Abstract][Full Text] [Related]
14. Granular tau oligomers as intermediates of tau filaments.
Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
[TBL] [Abstract][Full Text] [Related]
15. Propagation of Tau Aggregates and Neurodegeneration.
Goedert M; Eisenberg DS; Crowther RA
Annu Rev Neurosci; 2017 Jul; 40():189-210. PubMed ID: 28772101
[TBL] [Abstract][Full Text] [Related]
16. Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.
Brunden KR; Ballatore C; Crowe A; Smith AB; Lee VM; Trojanowski JQ
Exp Neurol; 2010 Jun; 223(2):304-10. PubMed ID: 19744482
[TBL] [Abstract][Full Text] [Related]
17. Conformational features of tau fibrils from Alzheimer's disease brain are faithfully propagated by unmodified recombinant protein.
Morozova OA; March ZM; Robinson AS; Colby DW
Biochemistry; 2013 Oct; 52(40):6960-7. PubMed ID: 24033133
[TBL] [Abstract][Full Text] [Related]
18. Are tangles as toxic as they look?
Spires-Jones TL; Kopeikina KJ; Koffie RM; de Calignon A; Hyman BT
J Mol Neurosci; 2011 Nov; 45(3):438-44. PubMed ID: 21638071
[TBL] [Abstract][Full Text] [Related]
19. Assembly of recombinant tau into filaments identical to those of Alzheimer's disease and chronic traumatic encephalopathy.
Lövestam S; Koh FA; van Knippenberg B; Kotecha A; Murzin AG; Goedert M; Scheres SHW
Elife; 2022 Mar; 11():. PubMed ID: 35244536
[TBL] [Abstract][Full Text] [Related]
20. Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons over-expressing mutant tau.
Guo JL; Lee VM
FEBS Lett; 2013 Mar; 587(6):717-23. PubMed ID: 23395797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
